Quantification of residual disease in chronic myeloid leukemia patients treated by interferon using interphase FISH and competitive RT-PCR

被引：0
|
作者：
Tchirkov, A
Giollant, M
Briancon, G
Travade, P
Tournilhac, O
Demeocq, F
Kuleshov, N
Malet, P
机构：
[1] UNIV AUVERGNE,FAC MED,CLERMONT FERRAN,FRANCE
[2] PEDIAT RES INST HEMATOL,MOSCOW,RUSSIA
来源：
CYTOGENETICS AND CELL GENETICS | 1997年 / 77卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：P325 / P325
页数：1
相关论文
共 50 条
  • [1] Residual disease monitoring in patients with chronic myeloid leukaemia (CML) treated with interferon-a by means of interphase cytogenetics and competitive RT-PCR
    Tchirkov, A
    Giollant, M
    Briançon, G
    Travade, P
    Tavernier, F
    Tournilhac, O
    Kwiatkowski, F
    Choufi, B
    Deméocq, F
    Malet, P
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 176 - 176
  • [2] Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-α therapy
    Tchirkov, A
    Giollant, M
    Tavernier, F
    Briançon, G
    Tournilhac, O
    Kwiatkowski, F
    Philippe, P
    Choufi, B
    Deméocq, F
    Travade, P
    Malet, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (03) : 552 - 557
  • [3] Relevance of conventional chromosome analysis, interphase-FISH, hypermetaphase-FISH and RT-PCR for the detection of residual disease in chronic myeloid leukemia
    Schoch, C
    Bursch, S
    Schnittger, S
    Haferlach, T
    Hiddemann, W
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 85 - 85
  • [4] Analysis of chronic myeloid leukemia (CML) cases with minimal disease after interferon treatment by means of interphase FISH and quantitative RT-PCR
    Tchirkov, A
    Giollant, M
    Briancon, G
    Travade, P
    Tavernier, F
    Tournilhac, O
    Deméocq, F
    Malet, P
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 87 - 87
  • [5] Detection of minimal residual disease in chronic myeloid leukemia using a real time quantitative RT-PCR assay
    Bouraoui, S.
    Dhouib, H.
    Boughriba, R.
    Weslati, M.
    Ounissi, D.
    Hazgui, M.
    Dhraief, M.
    Mezabi, S. Regaya
    VIRCHOWS ARCHIV, 2015, 467 : S199 - S199
  • [6] COMPLETE CYTOGENETIC CONVERSION (CCC) IN CHRONIC MYELOCYTIC-LEUKEMIA PATIENTS UNDERGOING INTERFERON THERAPY - EVALUATION OF THE MINIMAL RESIDUAL DISEASE USING NESTED RT-PCR COMPARED WITH COMPETITIVE PCR
    BILHOUNABERA, C
    MARIT, G
    GHARBI, MJ
    SALZES, S
    REIFFERS, J
    BROUSTET, A
    BERNARD, P
    BLOOD, 1994, 84 (10) : A152 - A152
  • [7] Combined RT-PCR and metaphase-FISH posttransplant studies in pediatric patients with chronic myeloid leukemia
    Vettenranta, K
    Huhta, T
    Lindlof, M
    Knuutila, S
    Saarinen-Pihkala, UM
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (02) : 108 - 111
  • [8] Minimal residual disease (MRD) monitoring by quantitative RT-PCR (RQ PCR) and FISH in chronic myelogenous leukemia (CML) patients treated with STI571 (Gleevec®).
    Roche, C
    Grardel, N
    Cornu-Soenen, V
    Laï, JL
    Roumier, C
    Berthaud, P
    Chatelain, N
    Cosson, A
    Facon, T
    Preudhomme, C
    BLOOD, 2001, 98 (11) : 615A - 615A
  • [9] Complemental roles for multiparameter flow cytomety and quantitative RT-PCR for the quantification of minimal residual disease in patients with acute myeloid leukemia.
    Kern, W
    Schoch, C
    Haferlach, T
    Voskova, D
    Hiddemann, W
    Schnittger, S
    BLOOD, 2003, 102 (11) : 65A - 65A
  • [10] SIGNIFICANCE OF RT-PCR AND FISH AS MINIMAL RESIDUAL DISEASE (MRD) IN PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA (AL)
    Aguilar, Rocio Yemeli Buenrostro
    Cabrera, Daniela Arce
    Guzman, Jorge
    Altamirano, Eduardo
    Lozano, Jose Rodrigo
    Aguilar, Guadalupe Valenzuela
    Guzman, Obdilia Gutierrez
    Echeverria, Maite
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S575 - S575
12345